| 1 (31) | Samsung Corp * | MUL |  |
| 2 (94) | Toyota Group * | MUL | |
| 3 (103) | F Hoffmann-La Roche * | MUL | |
| 4 (147) | AstraZeneca * | MUL | |
| 5 (168) | Alphabet Inc * | MUL | |
| 6 (174) | Bristol-Myers Squibb Company * | MUL | |
| 7 (177) | GlaxoSmithKline * | MUL | |
| 8 (180) | Novartis * | MUL | |
| 9 (185) | Merck * | MUL | |
| 10 (186) | Sumitomo Group * | MUL | |
| 11 (192) | Siemens * | MUL | |
| 12 (201) | Biogen Idec * | MUL | |
| 13 (206) | European Commission - Joint Research Centre | MUL |  |
| 14 (213) | European Commission * | MUL | |
| 15 (217) | Johnson & Johnson * | MUL | |
| 16 (222) | Sanofi * | MUL | |
| 17 (236) | Pfizer * | MUL | |
| 17 (236) | IBM Research * | MUL | |
| 19 (247) | Janssen | MUL | |
| 20 (248) | Gilead Sciences * | MUL | |
| 21 (260) | General Electric Company * | MUL | |
| 22 (265) | Hitachi * | MUL | |
| 23 (276) | Amgen * | MUL | |
| 24 (289) | Boehringer Ingelheim * | MUL | |
| 25 (299) | Robert Bosch * | MUL | |
| 26 (302) | Novo Nordisk * | MUL | |
| 27 (303) | Eli Lilly * | MUL | |
| 28 (313) | Bayer * | MUL | |
| 29 (335) | Koninklijke Philips NV * | MUL | |
| 30 (363) | AbbVie * | MUL | |
| 31 (399) | Takeda Pharmaceuticals International Inc * | MUL | |
| 32 (434) | Danone * | MUL | |
| 33 (439) | UCB Pharma SA * | MUL | |
| 34 (440) | DowDupont * | MUL | |
| 35 (453) | BASF Group * | MUL | |
| 36 (469) | GE Healthcare | MUL | |
| 37 (470) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 38 (480) | Syngenta * | MUL | |
| 39 (495) | Medtronic * | MUL | |
| 40 (501) | Nestle * | MUL | |
| 41 (537) | Unilever * | MUL | |
| 42 (572) | Allergan plc * | MUL | |
| 43 (581) | International Centre for Genetic Engineering and Biotechnology * | MUL | |
| 44 (606) | Springer Nature * | MUL | |
| 45 (610) | Netherlands Organisation for Applied Scientific Research * | MUL | |
| 46 (643) | Abbott Laboratories * | MUL | |
| 47 (650) | Heriot-Watt University * | MUL |  |
| 48 (652) | Manipal Global Education Group * | MUL | |
| 49 (746) | Laureate International Universities * | MUL | |
| 50 (768) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 51 (916) | RELX Group plc * | MUL | |
|
